Strategies to combat antimicrobial resistance: Anti-plasmid and plasmid curing

FEMS Microbiology Reviews

Volumn 42, Issue 6, 2018, Pages 781-804

  Buckner, Michelle M C ^a   Ciusa, Maria Laura ^a   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Antibiotics; Antimicrobial resistance; Conjugation inhibitors; CRISPR Cas; Plasmid; Plasmid curing

Indexed keywords

AMINOCOUMARIN DERIVATIVE; ASCORBIC ACID; BIOCIDE; CHLORPROMAZINE; DETERGENT; GYRASE INHIBITOR; INTERCALATING AGENT; PHYTOCHEMICAL; PSYCHOTROPIC AGENT; QUINOLONE DERIVATIVE; RIFAMPICIN; UNSATURATED FATTY ACID; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIOPHAGE; CONJUGATION; CRISPR CAS SYSTEM; HUMAN; NONHUMAN; PLASMID; REVIEW; ANIMAL; BACTERIAL GENE; BACTERIUM; DRUG EFFECT; ENVIRONMENTAL MICROBIOLOGY; GENETICS; HORIZONTAL GENE TRANSFER;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; ENVIRONMENTAL MICROBIOLOGY; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; HUMANS; PLASMIDS;

EID: 85055611544     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1093/femsre/fuy031     Document Type: Review

References (198)

1. Adeyemo SM, Onilude AA. Plasmid curing and its effect on the growth and physiological characteristics of Lactobacillus plantarum isolated from fermented cereals. J Microbiol Res 2015;5:11–22.
2. Ahmad S, Kitchin KT, Cullen WR. Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin. Toxicol Lett 2002;133:47–57.
3. Amábile Cuevas CF. Loss of penicillinase plasmids of Staphylococcus aureus after treatment with L-ascorbic acid. Mutat Res Lett 1988;207:107–9.
4. Amábile-Cuevas CF, Piña-Zentella RM, Wah-Laborde ME. Decreased reistance to antibiotics and plasmid loss in plasmid-carrying strains of Staphylocccus aureus treated with ascorbic acid. Mutat Res Lett 1991;264:119–25.
5. Amaral L, Viveiros M, Molnar J. Antimicrobial activity of phenothiazines. In Vivo (Brooklyn) 2004;18:725–32.
6. Amos GCA, Hawkey PM, Gaze WH et al. Waste water effluent contributes to the dissemination of CTX-M-15 in the natural environment. J Antimicrob Chemoth 2014;69:1785–91.
7. Andriole VT. The quinolones: past, present, and future. Clin Infect Dis 2005;41:S113–9.
8. Arcilla MS, van Hattem JM, Haverkate MR et al. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis 2017;17:78–85.
9. Aviv G, Rahav G, Gal-mor O. Horizontal transfer of the Salmonella enterica serovar infantis resistance and virulence plasmid pesi to the gut microbiota of warm-blooded hosts. mBio 2016;7:1–12.
10. Aviv G, Tsyba K, Steck N et al. A unique megaplasmid contributes to stress tolerance and pathogenicity of an emergent Salmonella enterica serovar Infantis strain. Environ Microbiol 2014;16:977–94.
11. Axelsson LT, Ahrné SEI, Andersson MC et al. Identification and cloning of a plasmid-encoded erythromycin resistance determinant from Lactobacillus reuteri. Plasmid 1988;20:171–4.
12. Aydin S, Personne Y, Newire E et al. Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli. J Antimicrob Chemoth 2017;72:2213–8.
13. Banuelos-Vazquez LA, Torres Tejerizo G, Brom S. Regulation of conjugative transfer of plasmids and integrative conjugative elements. Plasmid 2017;91:82–89.
14. Baxter JC, Funnell BE. Plasmid partition mechanisms. Microbiol Spectr 2014;2:1–20.
15. Bazzicalupo P, Tocchini-Valentini GP. Curing of an Escherichia coli episome by rifampicin. P Natl Acad Sci USA 1972;69:298–300.
16. Beg AZ, Ahmad I. Effect of Plumbago zeylanica extract and certain curing agents on multidrug resistant bacteria of clinical origin. World J Microb Biot 2000;16:841–4.
17. Bell G, MacLean C. The search for “evolution-proof” antibiotics. Trends Microbiol 2018;26:471–83.
18. Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M beta-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemoth 2017;72:2145–55.
19. Bharathi A, Polasa H. Elimination of broad-host range plasmid vectors in Escherichia coli by curring agents. FEMS Microbiol Lett 1991;84:37–40.
20. Bikard D, Euler CW, Jiang W et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol 2014;32:1146–50.
21. Borah D, Yadav, RNS. Plasmid curing of a novel hydrocarbon degrading Bacillus cereus strain DRDU1 revealed its involvement in petroleum oil degradation. J Pet Env Biotechnol 2015;6:1–4.
22. Bouanchaud DH, Chabbert YA. Practical effectiveness of agents curing R factors and plasmids. Ann NY Acad Sci 1971;65:305–11.
23. Bouanchaud DH, Scavizzi MR, Chabbert YA. Elimination by ethidium bromide of antibiotic resistance in Enterobacteria and Staphylococci. J Gen Microbiol 1968;54:417–25.
24. Brandi L, Falconi M, Ripa S. Plasmid curing effect of trovafloxacin. FEMS Microbiol Lett 2000;184:297–302.
25. Bringel F, Frey L, Hubert JC. Characterization, cloning, curing, and distribution in lactic acid bacteria of pLP1, a plasmid from Lactobacillus plantarum CCM 1904 and its use in shuttle vector construction. Plasmid 1989;22:193–202.
26. Cabello FC. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol 2006;8:1137–44.
27. Cabezon E, Ripoll-Rozada J, Pena A et al. Towards an integrated model of bacterial conjugation. FEMS Microbiol Rev 2015;39:81–95.
28. Cao Q-H, Shao H-H, Qiu H et al. Using the CRISPR/Cas9 system to eliminate native plasmids of Zymomonas mobilis ZM4. Biosci Biotechnol Biochem 2017;81:453–9.
29. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Ch 2009;53:2227–38.
30. Carattoli A. Plasmids in Gram negatives: Molecular typing of resistance plasmids. Inte J Med Microbiol 2011;301:654–8.
31. Carattoli A. Plasmids and the spread of resistance. Int J Med Microbiol 2013;303:298–304.
32. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Meth 2005;63:219–28.
33. Carmo LP, Schüpbach-Regula G, Müntener C et al. Approaches for quantifying antimicrobial consumption per animal species based on national sales data: a Swiss example, 2006 to 2013. Euro Surveill 2017;22:30458.
34. Caro LG, Schnös M. The attachment of the male-specific bacteriophage F1 to sensitive strains of Escherichia coli. P Natl Acad Sci USA 1966;56:126–32.
35. Casu B, Arya T, Bessette B et al. Fragment-based screening identifies novel targets for inhibitors of conjugative transfer of antimicrobial resistance by plasmid pKM101. Sci Rep 2017;7:14907.
36. Casu B, Smart J, Hancock MA et al. Structural analysis and inhibition of TraE from the pKM101 type IV secretion system. J Biol Chem 2016;291:23817–29.
37. Chan BK, Sistrom M, Wertz JE et al. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci Rep 2016;6:26717.
38. Chan WT, Espinosa M, Yeo CC. Keeping the wolves at bay: antitoxins of prokaryotic type II toxin-antitoxin systems. Front Mol Biosci 2016;3:9.
39. Chassy BM, Gibson EM, Guiffrida A. Evidence for plasmid-associated lactose metabolism in Lactobacillus casei subsp.casei. Curr Microbiol 1978;1:141–4.
40. Chin SC, Abdullah N, Siang TW et al. Plasmid profiling and curing of Lactobacillus strains isolated from the gastrointestinal tract of chicken. J Microbiol 2005;43:251–6.
41. Chiou SH, Chang WC, Jou YS et al. Specific cleavages of DNA by ascorbate in the presence of copper ion or copper chelates. J Biochem 1985;98:1723–6.
42. Chuanchuen R, Beinlich K, Hoang TT et al. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Age Ch 2001;45: 428–32.
43. Citorik RJ, Mimee M, Lu TK. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol 2014;32:1141–5.
44. Coleri A, Cokmus C, Ozcan B et al. Determination of antibiotic resistance and resistance plasmids of clinical Enterococcus species. J Gen Appl Microbiol 2004;50:213–9.
45. Conte D, Palmeiro JK, da Silva Nogueira K et al. Characterization of CTX-M enzymes, quinolone resistance determinants, and antimicrobial residues from hospital sewage, wastewater treatment plant, and river water. Ecotoxicol Environ Safe 2017;136:62–69.
46. Costa SS, Ntokou E, Martins A et al. Identification of the plasmid-encoded qacA efflux pump gene in meticillin-resistant Staphylococcus aureus (MRSA) strain HPV107, a representative of the MRSA Iberian clone. Int J Antimicrob Ag 2010;36:557–61.
47. Cottell JL, Webber MA, Coldham NG et al. Complete sequence and molecular epidemiology of IncK epidemic plasmid encoding bla CTX-M-14. Emerg Infect Dis 2011;17:645–52.
48. Courtright JB, Turowski DA, Sonstein SA. Alteration of bacterial DNA structure, gene expression, and plasmid encoded antibiotic resistance following exposure to enoxacin. J Antimicrob Chemoth 1988;21:1–18.
49. Crofts TS, Gasparrini AJ, Dantas G. Next-generation approaches to understand and combat the antibiotic resistome. Nat Rev Microbiol 2017;15:422–34.
50. Danilevskaya ON, Gragerov AI. Curing of Escherichia coli K12 plasmids by coumermycin. Mol Gen Genet 1980;178:233–5.
51. Dastidar S, Kristiansen J, Molnar J et al. Role of phenothiazines and structurally similar compounds of plant origin in the fight against infections by drug resistant bacteria. Antibiotics 2013;2:58–72.
52. Denap JCB, Thomas JR, Musk DJ et al. Combating drug-resistant bacteria: small molecule mimics of plasmid incompatibility as antiplasmid compounds. J Am Chem Soc 2004;126:15402–4.
53. Dionisio F. Plasmids surive despite their cost and male-specific phages due to heterogeneity of bacterial populations. Evol Ecol Res 2005;7:1089–107.
54. ECDC. Surveillance of antimicrobial resistance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network 2016:1–100.
55. El-Mansi M, Anderson KJ, Inche CA et al. Isolation and curing of the Klebsiella pneumoniae large indigenous plasmid using sodium dodecyl sulphate. Res Microbiol 2000;151:201–8.
56. Ersfeld-Dressen H, Sahl H-G, Brandis H. Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep 5. Microbiology 1984;130:3029–35.
57. Fernandez-Lopez R, Machon C, Longshaw CM et al. Unsaturated fatty acids are inhibitors of bacterial conjugation. Microbiology 2005;151:3517–26.
58. Fernando DM, Xu W, Loewen PC et al. Triclosan can select for an AdeIJK-overexpressing mutant of Acinetobacter baumannii ATCC 17978 that displays reduced susceptibility to multiple antibiotics. Antimicrob Agents Ch 2014;58:6424–31.
59. Fu KP, Grace ME, Hsiao CL et al. Elimination of antibiotic-resistant plasmids by quinolone antibiotics. Chemotherapy 1988;34:415–8.
60. Gantzhorn MR, Olsen JE, Thomsen LE. Importance of sigma factor mutations in increased triclosan resistance in Salmonella Typhimurium. BMC Microbiol 2015;15:105.
61. García-Quintanilla M, Prieto AI, Barnes L et al. Bile-induced curing of the virulence plasmid in Salmonella enterica serovar typhimurium. J Bacteriol 2006;188:7963–5.
62. García-Quintanilla M, Ramos-Morales F, Casadesús J. Conjugal transfer of the Salmonella enterica virulence plasmid in the mouse intestine. J Bacteriol 2008;190:1922–7.
63. Garneau JE, Dupuis ME, Villion M et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010;468:67–71.
64. Gellert M, O’Dea MH, Itoh T et al. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. P Natl Acad Sci USA 1976;73:4474–8.
65. Getino M, de la Cruz F. Natural and artificial strategies to control the conjugative transmission of plasmids. Microbiol Spectr 2018;6:MTBP-0015-2016.
66. Getino M, Fernandez-Lopez R, Palencia-Gandara C et al. Tanzawaic acids, a chemically novel set of bacterial conjugation inhibitors. PLoS ONE 2016;11:e0148098.
67. Getino M, Sanabria-Rios DJ, Fernandez-Lopez R et al. Synthetic fatty acids prevent plasmid-mediated horizontal gene transfer. mBio 2015;6:e01032–15.
68. Goessweiner-Mohr N, Arends K, Keller W et al. Conjugation in gram-positive bacteria. Microbiol Spectr 2014;2:PLAS-0004-2013.
69. Gomaa AA, Klumpe HE, Luo ML et al. Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. mBio 2014;5:e00928–13.
70. Gulig PA, Curtiss R, III. Plasmid- associated virulence of Salmonella typhimurium. Infect Immun 1987;55:2891–901.
71. Hahn FE, Ciak J. Elimination of resistance determinants from R-factor R1 by intercalative compounds. Antimicrob Agents Ch 1976;9:77–80.
72. Hale L, Lazos O, Haines A et al. An efficient stress-free strategy to displace stable bacterial plasmids. BioTechniques 2010;48:223–8.
73. Hall JPJ, Brockhurst MA, Dytham C et al. The evolution of plasmid stability: Are infectious transmission and compensatory evolution competing evolutionary trajectories? Plasmid 2017;91:90–95.
74. Harrison E, Wood AJ, Dytham C et al. Bacteriophages limit the existence conditions for conjugative plasmids. mBio 2015;6:e00586–15.
75. Hernandez A, Ruiz FM, Romero A et al. The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia. PLoS Pathog 2011;7:e1002103.
76. Heuer H, Binh CTT, Jechalke S et al. IncP-1ε plasmids are important vectors of antibiotic resistance genes in agricultural systems: diversification driven by class 1 integron gene cassettes. Front Microbio 2012;3:2.
77. Holmes AH, Moore LS, Sundsfjord A et al. Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet 2016;387:176–87.
78. Hooper DC, Wolfson JS, McHugh GL et al. Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase. Antimicrob Agents Ch 1984;25:586–90.
79. Hovi M, Sukupolvi S, Edwards MF et al. Plasmid-associated virulence of Salmonella enteritidis. Microbial Pathog 1988;4:385–91.
80. Hulter N, Ilhan J, Wein T et al. An evolutionary perspective on plasmid lifestyle modes. Curr Opin Microbiol 2017;38:74–80.
81. Ilangovan A, Connery S, Waksman G. Structural biology of the Gram-negative bacterial conjugation systems. Trends Microbiol 2015;23:301–10.
82. Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr 2014;2:PLAS-0006-2013.
83. Jahagirdar S, Patwardhan R, Dhakephalkar PK. Curing plasmid-mediated vancomycin resistance in Staphylococcus aureus using herbal naphthoquinones. J Hosp Infect 2008;70:289–91.
84. Jalasvuori M, Friman V-P, Nieminen A et al. Bacteriophage selection against a plasmid-encoded sex apparatus leads to the loss of antibiotic-resistance plasmids. Biol Lett 2011;7:902–5.
85. Jetten AM, Vogels GD. Characterization and extrachromosomal control of bacteriocin production in Staphylococcus aureus. Antimicrob Agents Ch 1973;4:49–57.
86. Jiang F, Doudna JA. The structural biology of CRISPR-Cas systems. Curr Opin Struct Biol 2015;30:100–11.
87. Johnston JH, Richmond MH. The increased rate of loss of penicillinase plasmids from Staphylococcus aureus in the presence of rifampicin. J Gen Microbiol 1970;60:137–9.
88. Kado CI. Historical events that spawned the field of plasmid biology. Microbiol Spectr 2014;2:PLAS-0019-2013.
89. Kamruzzaman M, Shoma S, Thomas CM et al. Plasmid interference for curing antibiotic resistance plasmids in vivo. PLoS ONE 2017;12:e0172913.
90. Karthikeyan V, Santosh SW. Comparing the efficacy of plasmid curing agents in Lactobacillus acidophilus. Benef Microbes 2010;1:155–8.
91. Keyhani J, Keyhani E, Attar F et al. Sensitivity to detergents and plasmid curing in Enterococcus faecalis. J Ind Microbiol Biot 2006;33:238–42.
92. Kim JS, Cho DH, Park M et al. CRISPR/Cas9-mediated re-sensitization of antibiotic-resistant Escherichia coli harboring extended-spectrum beta-lactamases. J Microbiol Biot 2016;26:394–401.
93. Kristoffersen SM, Ravnum S, Tourasse NJ et al. Low concentrations of bile salts induce stress responses and reduce motility in Bacillus cereus ATCC 14570. J Bacteriol 2007;189:5302–13.
94. Lai C-C, Chuang Y-C, Chen C-C et al. Coexistence of MCR-1 and NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate. Int J Antimicrob Ag 2017;49:517–8.
95. Lakhmi VV, Padma S, Polasa H. Elimination of multidrug-resistant plasmid in bacteria by plumbagin, a compound derived from a plant. Curr Microbiol 1987;16:159–61.
96. Lakshmi VV, Thomas CM. Curing of F-like plasmid TP181 by plumbagin is due to interference with both replication and maintenance functions. Microbiology 1996;142:2399–406.
97. Latha C, Shriram VD, Jahagirdar SS et al. Antiplasmid activity of 1-acetoxychavicol acetate from Alpinia galanga against multi-drug resistant bacteria. J Ethnopharmacol 2009;123:522–5.
98. Lavanya B, Sowmiya S, Balaji S et al. Plasmid profiling and curing of Lactobacillus strains isolated from fermented milk for probiotic applications. Adv J Food Sci Technol 2011;3:95–101.
99. Laxminarayan R, Matsoso P, Pant S et al. Access to effective antimicrobials: a worldwide challenge. Lancet 2016;387:168–75.
100. Letchumanan V, Pusparajah P, Tan LTH et al. Occurrence and antibiotic resistance of Vibrio parahaemolyticus from Shellfish in Selangor, Malaysia. Front Microbiol 2015;6:1–11.
101. Levine M, Conry-Cantilena C, Wang Y et al. Vitamin C phar-macokinetics in healthy volunteers: evidence for a recommended dietary allowance. P Natl Acad Sci USA 1996;93:3704–9.
102. Li A-D, Li L-G, Zhang T. Exploring antibiotic resistance genes and metal resistance genes in plasmid metagenomes from wastewater treatment plants. Front Microbiol 2015;6:1025.
103. Lin A, Jimenez J, Derr J et al. Inhibition of bacterial conjugation by phage M13 and its protein g3p: quantitative analysis and model. PLoS ONE 2011;6:e19991.
104. Lin TL, Pan YJ, Hsieh PF et al. Imipenem represses CRISPR-Cas interference of DNA acquisition through H-NS stimulation in Klebsiella pneumoniae. Sci Rep 2016;6:31644.
105. Liu P-Y, Jiang N, Zhang J et al. The oxidative damage of plasmid DNA by ascorbic acid derivatives in vitro: the first research on the relationship between the structure of ascorbic acid and the oxidative damage of plasmid DNA. Chem Biodivers 2006;3:958–66.
106. Liu X, Wang D, Wang H et al. Curing of plasmid pXO1 from Bacillus anthracis using plasmid incompatibility. PLoS ONE 2012;7:e29875.
107. Liu Y-Y, Wang Y, Walsh TR et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16:161–8.
108. Llanes C, Michel-Briand Y, Thouverez M et al. Stability of conjugative and non-conjugative R-plasmids from Serratia marcescens to gyrase inhibitors. Microbiologica 1990;13:157–9.
109. Lopatkin AJ, Meredith HR, Srimani JK et al. Persistence and reversal of plasmid-mediated antibiotic resistance. Nat Commun 2017;8:1689.
110. McHugh GL, Swartz MN. Elimination of plasmids from several bacterial species by novobiocin. Antimicrob Agents Ch 1977;12:423–6.
111. MacLean RC, San Millan A. Microbial evolution: towards resolving the plasmid paradox. Curr Biol 2015;25:R764–7.
112. Maier L, Pruteanu M, Kuhn M et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:623–8.
113. Mandi TY, Molnar J, Holland IB et al. Efficient curing of an Escherichia coli F-prime plasmid by phenothiazines. Genet Res 1975;26:109–11.
114. Meek RW, Vyas H, Piddock LJ. Nonmedical uses of antibiotics: time to restrict their use? PLoS Biol 2015;13:e1002266.
115. Mesas JM, Rodriguez MC, Alegre MT. Plasmid curing of Oenococcus oeni. Plasmid 2004;51:37–40.
116. Michel-briand Y, Uccedi V, Laporte J et al. Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives. J Antimicrob Chemoth 1986;18:667–74.
117. Mitchell I, Kenworthy R. Attempted elimination of plasmid-determined haemolysin, k88 antigen and enterotoxin from Escherichia coli pathogenic for pigs. J Appl Bacteriol 1977;42:207–12.
118. Molnár A, Amaral L, Molnár J. Antiplasmid effect of promethazine in mixed bacterial cultures. Int J Antimicrob Ag 2003;22:217–22.
119. Molnar J, Mandi Y, Kiraly J. Antibacterial effect of some phe-nothiazine compounds and R-factor elimination by chlorpromazine. Acta Microbiol Acad Sci Hung 1976;23:45–54.
120. Molnar J, Schneider B, Mandi Y et al. New mechanism of plasmid curing by psychotropic drugs. Acta Microbiol Acad Sci Hung 1980;27:309–15.
121. Morgan AR, Cone RL, Elgert TM. The mechanism of DNA strand breakage by vitamin C and superoxide and the protective roles of catalase and superoxide dismutase. Nucleic Acids Res 1976;3:1139–50.
122. Naas T, Oueslati S, Bonnin RA et al. Beta-lactamase database (BLDB) – structure and function. J Enzym Inhib Med Ch 2017;32:917–9.
123. Nakae M, Inoue M, Mitsuhashi S. Artificial elimination of drug resistance from group A beta-hemolytic Streptococci. Antimicrob Agents Ch 1975;7:719–20.
124. Ni B, Du Z, Guo Z et al. Curing of four different plasmids in Yersinia pestis using plasmid incompatibility. Lett Appl Microbiol 2008;47:235–40.
125. Novick RP. Plasmid incompatibility. Microbiol Rev 1987;51:381–95.
126. O’Connell CM, Nicks KM. A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced in-fectivity in cell culture. Microbiology 2006;152:1601–7.
127. O’Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations the Review on Antimicrobial Resistance. 2016, https://arm-review.org/publications.html.
128. Ohlow MJ, Moosmann B. Phenothiazine: the seven lives of pharmacology’s first lead structure. Drug Discov Today 2011;16:119–31.
129. Ojala V, Laitalainen J, Jalasvuori M. Fight evolution with evolution: plasmid-dependent phages with a wide host range prevent the spread of antibiotic resistance. Evol Appl 2013;6:925–32.
130. Oliva B, Selan L, Ravagnan G et al. Inhibition of conjugal transfer by new quinolinic compounds. Chemioterapia 1985;4:199–201.
131. Orlek A, Stoesser N, Anjum MF et al. Plasmid classification in an era of whole-genome sequencing: application in studies of antibiotic resistance epidemiology. Front Microbiol 2017;8:1–10.
132. Padhye S, Dandawate P, Yusufi M et al. Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev 2012;32:1131–58.
133. Paltansing S, Vlot JA, Kraakman ME et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis 2013;19:1206–13.
134. Paschos A, den Hartigh A, Smith MA et al. An in vivo high-throughput screening approach targeting the type IV secretion system component VirB8 identified inhibitors of Brucella abortus 2308 proliferation. Infect Immun 2011;79:1033–43.
135. Patwardhan RB, Shinde PS, Chavan KR et al. Reversal of plasmid encoded antibiotic resistance from nosocomial pathogens by using Plumbago auriculata root extracts. Int J Curr Microbiol Appl Sci 2015;2:187–98.
136. Peters JM, Silvis MR, Zhao D et al. Bacterial CRISPR: Accomplishments and prospects. Curr Opin Microbiol 2015;27:121–6.
137. Phillips AC, Towner KJ. Use of a non-radioactive DNA hybridization technique to study the effect of quinolone antibiotics on plasmid replication and caring. J Antimicrob Chemoth 1990;25:745–50.
138. Piddock LJV. Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol 2006;4:629–36.
139. Pinto UM, Pappas KM, Winans SC. The ABCs of plasmid replication and segregation. Nat Rev Microbiol 2012;10:755–65.
140. Pires J, Kuenzli E, Kasraian S et al. Polyclonal intestinal colonization with extended-spectrum cephalosporin-resistant Enterobacteriaceae upon traveling to India. Front Microbiol 2016;7:1069.
141. Platt DJ, Black AC. Plasmid ecology and tbe elimination of plasmids by 4-quinolones. J Antimicrob Chemoth 1987;20:137–8.
142. Poppe C, Gyles CL. Tagging and elimination of plasmids in Salmonella of avian origin. Vet Microbiol 1988;18:73–87.
143. Posno M, Leer RJ, van Luijk N et al. Incompatibility of Lactobacillus vectors with replicons derived from small cryptic lactobacillus plasmids and segregational instability of the introduced vectors. Appl Environ Microb 1991;57:1822–8.
144. Price VJ, Huo W, Sharifi A et al. CRISPR-Cas and restriction-modification act additively against conjugative antibiotic resistance plasmid transfer in Enterococcus faecalis. mSphere 2016;1:e00064–16.
145. Pulcrano G, Pignanelli S, Vollaro A et al. Isolation of Enterobacter aerogenes carrying bla TEM-1 and bla KPC-3 genes recovered from a hospital Intensive Care Unit. APMIS 2016;124:516–21.
146. Radhakrishnan V, Ganguly K, Ganguly M et al. Potentiality of tricyclic compound thioridazine as an effective antibacterial and antiplasmid agent. Indian J Exp Biol 1999;37:671–5.
147. Rahube TO, Marti R, Scott A et al. Persistence of antibiotic resistance and plasmid-associated genes in soil following application of sewage sludge and abundance on vegetables at harvest. Can J Microbiol 2016;62:600–7.
148. Raja CE, Selvam GS. Plasmid profile and curing analysis of Pseudomonas aeruginosa as metal resistant. Int J Environ Sci Technol 2009;6:259–66.
149. Ramesh A, Halami PM, Chandrashekar A. Ascorbic acid-induced loss of a pediocin-encoding plasmid in Pediococcus acidilactici CFR K7. World J Microb Biot 2000;16:695–7.
150. Rensch U, Nishino K, Klein G et al. Salmonella enterica serovar Typhimurium multidrug efflux pumps EmrAB and AcrEF support the major efflux system AcrAB in decreased susceptibility to triclosan. Int J Antimicrob Ag 2014;44:179–80.
151. Riber L, Burmolle M, Alm M et al. Enhanced plasmid loss in bacterial populations exposed to the antimicrobial compound irgasan delivered from interpenetrating polymer network silicone hydrogels. Plasmid 2016;87–88:72–78.
152. Ripoll-Rozada J, Garcia-Cazorla Y, Getino M et al. Type IV traffic ATPase TrwD as molecular target to inhibit bacterial conjugation. Mol Microbiol 2016;100:912–21.
153. Ripoll-Rozada J, Zunzunegui S, de la Cruz F et al. Functional interactions of VirB11 traffic ATPases with VirB4 and VirD4 molecular motors in type IV secretion systems. J Bacteriol 2013;195:4195–201.
154. Rodriguez-Martinez JM, Machuca J, Cano ME et al. Plasmid-mediated quinolone resistance: two decades on. Drug Resist Updates 2016;29:13–29.
155. Rosas SB, Calzolari A, La Torre JL et al. Involvement of a plasmid in Escherichia coli envelope alterations. J Bacteriol 1983;155:402–6.
156. Rotimi VO, Duerden BI, Hafiz S. Transferable plasmid-mediated antibiotic resistance in Bacteroides. J Med Microbiol 1981;14:359–70.
157. Rubin SJ, Rosenblum ED. Effects of ethidium bromide on growth and on loss of the penicillinase plasmid of Staphylococcus aureus. J Bacteriol 1971;108:1200–4.
158. Ruiz-Barba JL, Piard JC, Jiménez-Díaz R. Plasmid profiles and curing of plasmids in Lactobacillus plantarum strains isolated from green olive fermentations. J Appl Bacteriol 1991;71:417–21.
159. Ruiz-Maso JA, MachoN C, Bordanaba-Ruiseco L et al. Plasmid rolling-circle replication. Microbiol Spectr 2015;3:PLAS-0035-2014.
160. Sanofi-Aventis NZ. Data Sheet Largactil. http://www.medsafe.govt.nz/profs/Datasheet/l/largactiltabinjsusp.pdf 2016: largactil-ccdsv1-dsv8-05aug16.
161. Selan L, Scazzocchio F, Oliva B et al. Plasmid “curing” by some recently synthetized 4-quinolone compounds. Chemioterapia 1988;7:292–4.
162. Shintani M, Sanchez ZK, Kimbara K. Genomics of microbial plasmids: classification and identification based on replication and transfer systems and host taxonomy. Front Microbiol 2015;6:1–16.
163. Shriram V, Jahagirdar S, Latha C et al. A potential plasmid-curing agent, 8-epidiosbulbin E acetate, from Dioscorea bulbifera L. against multidrug-resistant bacteria. Int J Antimicrob Ag 2008;32:405–10.
164. Sonstein SA, Burnham JC. Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms. Diagn Microbiol Infect Dis 1993;16:277–89.
165. Spengler G, Miczák A, Hajdú E et al. Enhancement of plasmid curing by 9-aminoacridine and two phenothiazines in the presence of proton pump inhibitor 1-(2-benzoxazolyl)-3,3,3-trifluoro-2-propanone. Int J Antimicrob Ag 2003;22:223–7.
166. Spengler G, Molnár A, Schelz Z et al. The mechanism of plasmid curing in bacteria. Curr Drug Targets 2006;7:823–41.
167. Sternberg SH, Doudna JA. Expanding the Biologist’s Toolkit with CRISPR-Cas9. Mol Cell 2015;58:568–74.
168. Stoesser N, Sheppard AE, Pankhurst L et al. Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. mBio 2016;7:e02162–15.
169. Taylor DE, Levine JG. Characterization of a plasmid mutation affecting maintenance, transfer and elimination by novobiocin. Mol Gen Genet 1979;174:127–33.
170. Tomoeda M, Inuzuka M, Kubo N et al. Effective elimination of drug resistance and sex factors in Escherichia coli by sodium dodecyl sulfate. J Bacteriol 1968;95:1078–89.
171. Tyagi R, Menghani E. A Review on Plumbago zeylanica: a compelling herb. Int J Pharma Sci Res 2014;5:119–26.
172. Uraji M, Suzuki K, Yoshida K. A novel plasmid curing method using incompatibility of plant pathogenic Ti plasmids in Agrobacterium tumefaciens. Genes Genet Syst 2002;77:1–9.
173. Vading M, Kabir MH, Kalin M et al. Frequent acquisition of low-virulence strains of ESBL-producing Escherichia coli in travellers. J Antimicrob Chemoth 2016;71:3548–55.
174. Van Boeckel TP, Brower C, Gilbert M et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA 2015;112:5649–54.
175. Van Boeckel TP, Gandra S, Ashok A et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014;14:742–50.
176. Van Boeckel TP, Glennon EE, Chen D et al. Reducing antimicrobial use in food animals. Science 2017;357:1350–2.
177. Van Melderen L, Saavedra De Bast M. Bacterial toxin-antitoxin systems: more than selfish entities? PLoS Genet 2009;5:e1000437.
178. Varga B, Csonka Á, Csonka A et al. Possible biological and clinical applications of phenothiazines. Anticancer Res 2017;37:5983–93.
179. von Wintersdorff CJH, Wolffs PFG, van Niekerk JM et al. Detection of the plasmid-mediated colistin-resistance gene mcr-1 in faecal metagenomes of Dutch travellers. J Antimicrob Chemoth 2016;71:3416–9.
180. Wan Z, Goddard NL. Competition between conjugation and M13 phage infection in Escherichia coli in the absence of selection pressure: a kinetic study. G3 2012;2:1137–44.
181. Wang D, Gao Z, Wang H et al. Curing both virulent mega-plasmids from Bacillus anthracis wild-type strain A16 simultaneously using plasmid incompatibility. J Microbiol Biotechnol 2015;25:1614–20.
182. Wang H, Liu X, Feng E et al. Curing the plasmid pXO2 from Bacillus anthracis A16 using plasmid incompatibility. Curr Microbiol 2011;62:703–9.
183. Wang Y, Ness B Van. Site-specific cleavage of supercoiled DNA by ascorbate/Cu(II). Nucleic Acids Res 1989;17:6915–26.
184. Wang Y, Zhang R, Li J et al. Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production. Nat Microbiol 2017;2:16260.
185. Waring AJ, Drake IM, Schorah CJ et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 1996;38:171–6.
186. Webber MA, Buckner MMC, Redgrave LS et al. Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan. J Antimicrob Chemoth 2017;72:2755–63.
187. Webber MA, Randall LP, Cooles S et al. Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemoth 2008;62:83–91.
188. Webber MA, Whitehead RN, Mount M et al. Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure. J Antimicrob Chemoth 2015;70:2241–8.
189. Weisser J, Wiedemann B. Elimination of plasmids by new 4-quinolones. Antimicrob Agents Ch 1985;28:700–2.
190. Weisser J, Wiedemann B. Elimination of plasmids by enoxacin and ofloxacin at near inhibitory concentrations. J Antimicrob Chemoth 1986;18:575–83.
191. Wolfart K, Spengler G, Kawase M et al. Synergistic interaction between proton pump inhibitors and resistance modifiers: promoting effects of antibiotics and plasmid curing. In Vivo (Brooklyn) 2006;20:367–72.
192. Wolfson JS, Hooper DC, Swartz MN et al. Antagonism of the B subunit of DNA gyrase eliminates plasmids pBR322 and pMG110 from Escherichia coli. J Bacteriol 1982;152:338–44.
193. Wood DO, Carter MJ, Best GK. Plasmid-mediated resistance to gentamicin in Staphylococcus aureus. Antimicrob Agents Chemoth 1977;12:513–7.
194. Wright AV, Nuñez JK, Doudna JA. Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell 2016;164:29–44.
195. Yosef I, Goren MG, Globus R et al. Extending the host range of bacteriophage particles for DNA transduction. Mol Cell 2017;66:721–728.e3. e3.
196. Yosef I, Manor M, Kiro R et al. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci USA 2015;112:7267–72.
197. Zaman MA, Pasha MH, Akhter MZ. Plasmid curing of Escherichia coli cells with ethidium bromide, sodium dodecyl sulfate and acridine orange. Bangladesh J Microbiol 2010;27:28–31.
198. Zhou Y-F, Tao M-T, Feng Y et al. Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1. J Antimicrob Chemoth 2017;72:1723–30.